Renal Cancer - Results from #2640

Cohort Analysis of Epithelial Cancer Mortality Male-to-Female Sex Ratios in the European Union, USA, and Japan. August 3, 2020

Downregulation of SBF2-AS1 functions as a tumor suppressor in clear cell renal cell carcinoma by inhibiting miR-338-3p-targeted ETS1. August 3, 2020

Circadian clock is associated with tumor microenvironment in kidney renal clear cell carcinoma. July 31, 2020

Patients with sarcomatoid renal cell carcinoma - re-defining the first-line of treatment: A meta-analysis of randomised clinical trials with immune checkpoint inhibitors. July 31, 2020

Simultaneous versus staged partial nephrectomies for bilateral synchronous solid renal masses. July 31, 2020

The neutrophil-lymphocyte ratio has a role in predicting the effectiveness of nivolumab in Japanese patients with metastatic renal cell carcinoma: a multi-institutional retrospective study. July 30, 2020

Bioinformatics profiling integrating a four immune-related long non-coding RNAs signature as a prognostic model for papillary renal cell carcinoma. July 30, 2020

An evaluation of the tumour endothelial marker CLEC14A as a therapeutic target in solid tumours. July 30, 2020

PET imaging in urology: a rapidly growing successful collaboration. July 30, 2020

Xp11 translocation renal cell carcinoma with morphological features mimicking multilocular cystic renal neoplasm of low malignant potential: a series of six cases with molecular analysis. July 29, 2020

Does renal tumor biopsies for small renal carcinoma increase the risk of upstaging on final surgery pathology report and the risk of recurrence? July 29, 2020

Tivozanib, a highly potent and selective inhibitor of VEGF receptor tyrosine kinases, for the treatment of metastatic renal cell carcinoma. July 29, 2020

Identifying the novel key genes in renal cell carcinoma by bioinformatics analysis and cell experiments. July 28, 2020

Identification of a three-long noncoding RNA prognostic model involved competitive endogenous RNA in kidney renal clear cell carcinoma. July 28, 2020

Cytomorphology, immunoprofile, and management of renal oncocytic neoplasms. July 28, 2020

Small Renal Mass Surveillance: Histology-specific Growth Rates in a Biopsy-characterized Cohort. July 28, 2020

Cost-effectiveness of pembrolizumab with axitinib as first-line treatment for advanced renal cell carcinoma. July 27, 2020

Decreased mitochondrial DNA content drives OXPHOS dysregulation in chromophobe renal cell carcinoma. July 27, 2020

A new survival model based on ferroptosis-related genes for prognostic prediction in clear cell renal cell carcinoma. July 27, 2020

Association of CXCL13 and Immune Cell Infiltration Signature in Clear Cell Renal Cell Carcinoma. July 24, 2020

Page 133 of 457